Immune responses in hepatitis C virus infection: The role of dendritic cells

Immunology and Cell Biology

Volumn 81, Issue 1, 2003, Pages 63-66

  Fowler, Nina L ^a   Torresi, Joseph ^b   Jackson, David C ^b   Brown, Lorena E ^b   Gowans, Eric J ^a  

^a BURNET INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Dendritic cells; Hepatitis C virus; Immune response; Liver

Indexed keywords

ANTIGEN PRESENTATION; CELLULAR IMMUNITY; DENDRITIC CELL; HEPATITIS C; IMMUNE RESPONSE; IMMUNOTHERAPY; PERSISTENT INFECTION; SHORT SURVEY; T LYMPHOCYTE; VIRUS GENOME;

DENDRITIC CELLS; HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNE TOLERANCE; IMMUNOTHERAPY; LIVER; VACCINES;

HEPATITIS C VIRUS;

EID: 0037324198     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0818-9641.2002.01138.x     Document Type: Short Survey

References (34)

1. Miller RH, Purcell RH. Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant vires supergroups. Proc. Natl Acad. Sci. USA 1990; 87: 2057-61.
2. Alter HJ, Purcell RH, Shih JW et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N. Engl. J. Med. 1989; 321: 1494-500.
3. + T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur. J. Immunol. 2000; 30: 2479-87.
4. Lauer GM, Walker BD. Hepatitis C virus infection. N. Engl. J. Med. 2001; 345: 41-52.
5. Sherman KE, Rouster SD, Chung RT, Rajicic N. Hepatitis C virus prevalence among patients infected with human immunodeficiency vires: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin. Infect. Dis. 2002; 34: 831-7.
6. Benhamou Y, Bochet M, Di Martino V et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 1999; 30: 1054-8.
7. Soto B, Sanchez-Quijano A, Rodrigo L et al. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J. Hepatol. 1997; 26: 1-5.
8. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C vires infection. J. Exp. Med. 2001; 194: 1395-406.
9. Wang H, Eckels DD. Mutations in immunodominant T cell epitopes derived from the nonstructural 3 protein of hepatitis C virus have the potential for generating escape variants that may have important consequences for I cell recognition. J. Immunol. 1999; 162: 4177.
10. Eckels DD, Zhou H, Bian TH, Wang H. Identification of antigenic escape variants in an immunodominant epitope of hepatitis C virus. Int. Immunol. 1999; 11: 577-83.
11. Weiner A, Erickson AL, Kansopon J et al. Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proc. Natl Acad. Sci. USA 1995; 92: 2755-9.
12. Hoffmann RM, Diepolder HM, Zachoval R et al. Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection. Hepatology 1995; 21: 632-8.
13. Ferrari C, Valli A, Galati L et al. T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology 1994; 19: 286-95.
14. Diepolder HM, Gerlach JT, Zachoval R et al. Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection. J. Virol. 1997; 71: 6011-19.
15. Lamonaca V, Missale G, Urbani S et al. Conserved hepatitis C virus sequences are highly immunogenic for CD4 (+) T cells: implications for vaccine development. Hepatology 1999; 30: 1088-98.
16. Battisto JR, Bloom BR. Dual immunological unresponsiveness induced by cell membrane coupled hapten or antigen. Nature 1966; 212: 156-7.
17. Follett DA, Battisto JR, Bloom BR. Tolerance to a defined chemical hapten produced in adult guinea-pigs after thymectomy. Immunology 1966; 11: 73-6.
18. Calne RY. Immunological tolerance - the liver effect. Immunol. Rev. 2000; 174: 280.
19. Calne RY, Sells RA, Pena JR et al. Toleragenic effects of porcine liver allografts. Br. J. Surg. 1969; 56: 692-3.
20. Crispe IN, Dao T, Klugewitz K, Mehal WZ, Metz DP. The liver as a site of T-cell apoptosis: graveyard, or killing field? Immunol. Rev. 2000; 174: 47-62.
21. Bertolino P, Trescol-Biemont MC, Rabourdin-Combe C. Hepatocytes induce functional activation of naive CD8+ T lymphocytes but fail to promote survival. Eur. J. Immunol. 1998; 28: 221-36.
22. O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 1998; 8: 275.
23. Abe M, Akbar SM, Horiike N, Onji M. Induction of cytokine production and proliferation of memory lymphocytes by murine liver dendritic cell progenitors: role of these progenitors as immunogenic resident antigen-presenting cells in the liver. J. Hepatol. 2001; 34: 61-7.
24. Steinman RM. The dendritic ceil system and its role in immunogenicity. Annu. Rev. Immunol. 1991; 9: 271.
25. Galle MB, DeFranco RM, Kerjaschki D et al. Ordered array of dendritic cells and CD8+ lymphocytes in portal infiltrates in chronic hepatitis C. Histopathology 2001; 39: 373-81.
26. Caussin-Schwemling C, Schmitt C, Stoll-Keller F. Study of the infection of human blood derived monocyte/macrophages with hepatitis C virus in vitro. J. Med. Virol. 2001; 65: 14-22.
27. Lerat H, Rumin S, Habersetzer F et al. In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: influence of viral load, viral genotype, and cell phenotype. Blood 1998; 91: 3841-9.
28. Navas MC, Fuchs A, Schvoerer E, Bohbot A, Aubertin AM, Stoll-Keller F. Dendritic cell susceptibility to hepatitis C virus genotype I infection. J. Med. Virol. 2002; 67: 152-61.
29. Bain C, Fatmi A, Zoulim F, Zarski JP, Trepo C, Inchauspe G. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection. Gastroenterology 2001; 120: 512-24.
30. Kanto T, Hayashi N, Takehara T et al. Impaired allostimutatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals. J. Immunol. 1999; 162: 5584-91.
31. Auffermann-Gretzinger S, Keeffe EB, Levy S. Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood 2001; 97: 3171-6.
32. Kakumu S, Ito S, Ishikawa T et al. Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection. J. Gastroenterol. Hepatol. 2000; 15: 431-6.
33. Ito A, Kanto T, Kuzushita N et al. Generation of hepatitis C virus-specific cytotoxic T lymphocytes from healthy individuals with peptide-pulsed dendritic cells. J. Gastroenterol. Hepatol. 2001; 16: 309-16.
34. Sarobe PJJ, Lasarte N, Casares A et al. Abnormal priming of CD4 (+) T cells by dendritic cells expressing hepatitis C virus core and El proteins. J. Virol. 2002; 76: 5062.